July 2026
- CMS’ GLP-1 Bridge Demonstration
- Prone Positioning in Infants With Acute Bronchiolitis
- Insufficient Sleep Among US Adolescents
- So much depends
- When Patients Share Everything With An AI Chatbot
- Hearing Aids for Adults With Mild to Moderate Hearing Loss
- FDA Approves Additional Naloxone Nasal Spray for Opioid Overdose
- Bispecific Antibody Ivonescimab Added to Chemotherapy in EGFR -Variant Non–Small Cell Lung Cancer
- Strength Training Linked With Lower Cardiovascular Disease Risk in Women
- Heat Stress From Climate Change Surges Globally
- FDA Adds Kidney Injury Warning to OTC Weight-Loss Drug Orlistat
- US Dietary Supplement Use Increasing, Especially in Older Adults
- WHO Issues Guidelines for Treating Ebola and Marburg Viruses
- Review of Type 1 Diabetes
- Risk of False-Positives With Alzheimer Disease Blood Test
- Review of Type 1 Diabetes
- The HIV Reservoir Could Be Larger Than Thought
- Bispecific Antibody Ivonescimab Added to Chemotherapy in EGFR -Variant Non–Small Cell Lung Cancer Research Summary
- Deescalation, Discontinuation, and Deimplementation Trials
- Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease
- Effect of Information-Video Presenter Sex on Recruitment
- Audio Highlights July 2, 2026
- From Silicon Valley to the Vatican—The Expanding Debate on AI Ethics
- Insufficient Sleep Among US Adolescents—Reply
- Use of Social Media for Health Information Among US Adults
- “So much depends”: The Sestina and Learning Medicine
- Reporting Error
- Prone Positioning in Viral Bronchiolitis—Back to the Back?
- Replacement Text for Funding/Support Section
- Prone Positioning in Infants With Acute Bronchiolitis Research Summary
- Pricing for Oncology Biosimilars
- Review of Type 1 Diabetes
- Pricing for Oncology Biosimilars—Reply
- Review of Type 1 Diabetes—Reply
- Specialized or General-Purpose
- Farther, Faster, and More Often
- Training Health Speakers
- Patient Information: Adults With Mild to Moderate Hearing Loss
- Seymour Plan For Disease Prevention
- Rivaroxaban for Cardiovascular Disease Prevention in Chronic Kidney Disease
- Cesarean Delivery
- Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease Research Summary
- Cesarean Delivery—Reply
- Biomarker-Based Eligibility for Lung Cancer Screening
- JAMA